Medical Doctor Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Susan Murray

Forensic Psychiatry Tampa, FL Medical Doctor

NPI 1205933918 CMS profile 236335

5707 North 22Nd Street, Tampa, FL 33610

Open in the dashboard

General payments

$245

14 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Through program year 2020, Susan Murray of Tampa, FL is reported in the CMS Open Payments database as having received $245 across 14 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Forensic Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $92 5
2019 General $154 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Susan Murray
  • Forensic Psychiatry median
  • Middle half of Forensic Psychiatry
  • National median

In program year 2025, general payments to Susan Murray were reported at $0. Among 86 Forensic Psychiatry profiles paid that year, the median was $125 and the middle half received between $34 and $306.

Show as a table
Year Susan Murray Forensic Psychiatry median Middle half National median
2019 $154 $143 $61–$431 $163
2020 $92 $112 $36–$301 $114
2021 $0 $113 $38–$343 $132
2022 $0 $113 $67–$475 $149
2023 $0 $139 $66–$415 $160
2024 $0 $117 $36–$341 $164
2025 $0 $125 $34–$306 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Sunovion Pharmaceuticals Inc. $109 7 payments
  2. Vanda Pharmaceuticals Inc. $65 3 payments
  3. Otsuka America Pharmaceutical, Inc. $23 1 payment
  4. Neurocrine Biosciences, Inc. $17 1 payment
  5. Alkermes, Inc. $16 1 payment
  6. Janssen Pharmaceuticals, Inc $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Food and Beverage $245 14 payments
Products named General payments · program years 2019–2020
  1. LATUDA $109 7 payments
  2. HETLIOZ $65 3 payments
  3. FANAPT $29 1 payment
  4. ABILIFY MYCITE $23 1 payment
  5. INGREZZA $17 1 payment
  6. ARISTADA Cns $16 1 payment
  7. ARISTADA Cns $16 1 payment
  8. ARISTADA Cns $16 1 payment
  9. ARISTADA Cns $16 1 payment
  10. ARISTADA INITIO $16 1 payment
  11. Other $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

214

Median for Psychiatry: 574

Drug cost

$125,675

Median for Psychiatry: $27,624

Branded share of claims

21.5%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Invega Sustenna Paliperidone Palmitate Brand 35 $90,617
Abilify Maintena Aripiprazole Brand 11 $32,357
Aripiprazole Generic 15 $706
Benztropine Mesylate Generic 49 $657
Risperidone Generic 43 $539
Divalproex Sodium Generic 31 $492
Hydroxyzine Pamoate Generic 15 $232
Trazodone Hcl Generic 15 $74

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Records

14 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Forensic Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record